Wegovy® and Mounjaro® are both GLP-1 medications for weekly self-injection. While Wegovy® contains the active ingredient Semaglutide, Mounjaro® is based on the active ingredient Tirzepatide.
A scientific study showed that users at the highest dosage of Mounjaro can achieve an average weight loss of up to 20%.
In comparison, with Wegovy®, the weight loss is an average of 15%.